ConvaTec announced today that Paul Moraviec has joined the company as President of its Continence and Critical Care Business Unit and ConvaTec EMEA, which includes Europe, the Middle East and Africa.
Products
Smith & Nephew Introduces RENASYS GO Portable NPWT For Mobile, Active Patients
Smith & Nephew Inc’s Advanced Wound Management division announced the U.S. launch of its next Negative Pressure Wound Therapy product, the new RENASYS GO, designed to address the needs of clinicians and their active, mobile patients.
XTENT Receives CE Mark Approval for CUSTOM NX ® Drug-Eluting Stent System
XTENT, Inc. today announced that it has received CE Mark approval for its CUSTOM NX drug-eluting stent (DES) System.
‘New Class’ Of Coronary Stent Shows Sustained 12-Month Benefit
The CATANIA™ Coronary Stent System with NanoThin Polyzene®-F offers sustained benefit in the treatment of de novo coronary lesions and maximizes endothelialization, while reducing restenosis, thrombogenicity, and the need for long-term dual-antiplatelet therapy.
KCI Announces It Will Appeal German Patent Ruling
Kinetic Concepts, Inc. announced that the German Federal Patent Court has ruled that a German patent licensed to KCI from Wake Forest related to KCI’s V.A.C.® technology is invalid.
Edwards Lifesciences Prevails in German Patent Infringement Case Initiated by Cook
Edwards Lifesciences Corporation, the world leader in the science of heart valves, announced that the District Court of Düsseldorf, Germany, today determined that it does not infringe on Cook Inc.’s German transcatheter valve patent.
Venous Blood Clot Prevention after Hip or Knee Replacement Surgery: U.S. FDA Advisory Committee supports favorable benefit-risk profile of Bayer’s rivaroxaban
An Advisory Committee to the U.S. Food and Drug Administration met today to discuss the new drug application for Bayer’s rivaroxaban, a novel, oral anticoagulant taken as one tablet, once-daily for the prophylaxis of deep vein thrombosis and pulmonary embolism in patients undergoing hip or knee replacement surgery.
Positively Shocking News! The Worlds’ First Wearable Cardiac Defibrillator
A Cheshire based medical company Dot Medical, is the only UK Company to offer a unique life saving wearable ‘vest’ that monitors, detects and shocks people having a heart attack.
Invatec Receives CE-Mark For Second Drug-Eluting Balloon Platform
Invatec, a comprehensive innovator of interventional products, announced CE-certification of a new coronary balloon, the IN.PACT™ Falcon paclitaxel-eluting PTCA balloon catheter.
Harvard Study Favors Cayenne Medical’s AperFix Technology for Reconstruction of Torn ACL
Cayenne Medical, Inc. announced today that a new Harvard clinical study published in the American Journal of Sports Medicine found that Cayenne’s AperFix® System and “Single Tunnel, Double Bundle™” ACL reconstruction technique better resembles the natural, intact ACL when compared to the more common, “Single-Bundle” technique.
Arobella Medical Announces European CE Mark Approval of Qoustic Wound Therapy System™
Arobella Medical, LLC, announced European CE Mark approval of its Qoustic Wound Therapy System™ medical device for ultrasound aided wound care.
St. Jude Medical Announces FDA Approval Of New Features In Remote Patient Care For Implantable Cardiac Devices
St. Jude Medical, Inc. announced U.S. Food and Drug Administration approval of the newest version of the Merlin.net™ Patient Care Network, a secure, Internet-based remote care system for patients with implanted medical devices.
KARL STORZ and InTouch Health Announce Agreement to Expand Remote Presence into Integrated Operating Rooms
KARL STORZ Endoscopy-America, Inc., a world leader in minimally invasive endoscopic technologies and fully integrated operating room solutions, announces that it has entered into a definitive agreement with InTouch Health®, the world leader in Remote Presence healthcare solutions.
Edwards Lifesciences Completes Enrollment in Non-Surgical Study Arm of U.S. Clinical Trial for Transcatheter Valve
Edwards Lifesciences Corporation, the world leader in the science of heart valves, today announced completion of enrollment in the 350-patient non-surgical study arm of its U.S. pivotal trial — known as the PARTNER Trial — for the Edwards SAPIEN transcatheter aortic heart valve.
Pyng Medical Corp. Announces Election of Directors at 2009 Annual General Meeting and Executive Restructuring
Pyng Medical Corp. announced yesterday that at the Annual General Meeting of the shareholders held on March 11, 2009, the following persons were elected as directors: Robert (“Bob”) DiSilvio, Kevin O’Neill, Michael Jacobs, R.J. (“Bud”) Evans, Al Moloff and David Christie.
Flexible Stenting Solutions, Inc. Announces IDE Submission for FlexStent® Femoropopliteal Self Expanding Stent System
Flexible Stenting Solutions Inc. has submitted an Investigational Device Exemption application to the FDA for its FlexStent® Femoropopliteal SE Stent System for the treatment of peripheral artery disease in the superficial femoral and popliteal arteries.